Trial Profile
Exploratory phase IIIb trial of the effects of abatacept + methotrexate vs methotrexate alone on MRI changes in synovitis and structural damage in methotrexate-inadequate responders with active rheumatoid arthritis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 02 Sep 2015
Price :
$35
*
At a glance
- Drugs Abatacept (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 28 May 2011 Results presented at the 12th Annual Congress of the European League Against Rheumatism.
- 02 Mar 2011 New trial record